Menu
Home
Specialties
Services
Contact Janssen
Menu
Specialties
Services
Contact Janssen
Interesting Links
AMY DA site - i can identify - Video 4
Services
Media Center
It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.
Manage cookie settings
Chapters
00:00:15
Patients with monoclonal gammopathy of unknown significance,
00:00:20
smoldering multiple myeloma, or multiple myeloma,
00:00:25
when they present with unusual features of macroglossia
00:00:33
periorbital ecchymosis or racoon eyes,
00:00:36
or zero negative rheumatoid arthritis,
00:00:41
AL amyloidosis should be suspected and ruled out.
00:00:46
Patients who present with coagulopathy
00:00:50
related to acquired Factor X deficiency,
00:00:54
AL amyloidosis should always be in the differential diagnosis.
00:01:00
Patients with monoclonal gammopathy of unknown significance,
00:01:04
smoldering myeloma or myeloma presenting with heart failure,
00:01:11
shortness of breath, peripheral edema not related to steroids
00:01:16
should always be assessed for AL amyloidosis.
00:01:20
Congo red staining should be performed to rule out AL amyloidosis
00:01:26
as bone marrow biopsies with Congo red stain
00:01:30
can be positive in about 50% of the patients with AL amyloidosis.
00:01:42
I think it is crucial that the subspecialties collaborate with each other,
00:01:48
speak to each other, and see patients at the same time
00:01:52
to make the diagnosis quicker, easier, and emergently
00:01:58
so that the end organ function is preserved and does not deteriorate rapidly.
00:02:04
The other specialties besides hematology oncology and cardiology
00:02:09
are nephrology, neurology, as well as sometimes gastroenterology.
00:02:15
But I feel that the primary care doctors are the gatekeepers of healthcare system,
00:02:22
and raising awareness and having a high index of suspicion for a patient
00:02:28
with multiorgan involvement, multiorgan symptoms, is critical
00:02:35
for a primary care doctor to keep this diagnosis in mind.
00:02:39
As a systemic disease, there’s going to be other manifestations
00:02:42
that raise suspicion for AL cardiac amyloidosis.
00:02:46
And I think that’s what we do so well here at Boston University
00:02:50
where we all work together with multiple specialties,
00:02:54
and all of us see a single patient and then we discuss that patient in a group.
00:03:00
That also has implications for treatment, and Dr. Sanchorawala can talk more about that,
00:03:04
but people with cardiac amyloidosis may not tolerate certain treatments as well.
00:03:11
And so that’s really important to have a cardiologist who can talk to
00:03:14
the hematologist about the ability of a patient to tolerate certain therapies.
00:03:20
It is obtaining diagnosis quickly and non-invasively as possible.
00:03:26
And then, once the diagnosis is obtained, it is crucial to collaborate,
00:03:31
because the treatment side effects can be managed
00:03:34
by a multidisciplinary team appropriately.